FDA released a report containing immediate steps that can betaken to drive biomedical innovation, while improving the health of Americans.The report addresses concerns about the medical product development pipeline,one of the most pressing challenges facing the biomedical industries.
Release of the report, kicks off a new FDA-wide InnovationInitiative, which promises to redouble the agency’s efforts to encourage innovations that will promote public health as well as strengthen the American economy.
We are committed to continuing our dialogue with companies,innovators, patients, and other stakeholders to identify barriers to progressand better define what steps need to be taken to overcome any obstacles to innovation.
From U.S. Food and Drug Administration